Magnus Dillon is a Clinical Lecturer at the Institute of Cancer Research and Royal Marsden, London. He received his undergraduate medical degrees from the University of Cambridge and University College London, and PhD from the Institute of Cancer Research in 2018. He completed his clinical oncology training at ICR/Royal Marsden in 2020. His research interests include clinical and translational investigation of DNA damage response inhibitors in combination with radiotherapy, and the effect of combination therapies on the immune tumour microenvironment.